April 15, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
Biotechnology

Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence

By Newsroom
Last updated: October 26, 2025
1 Min Read
Share


Patent eligibility under 35 U.S.C. § 101 should be a straightforward threshold question: any “new and useful process, machine, manufacture, or composition of matter” is eligible for protection. Yet over time, this once-clear principle has become anything but.

Although the statute itself has remained unchanged for two centuries, its interpretation has evolved dramatically through judicial decisions. And it is this common law precedent that has shaped the approach to the determination of patent subject matter eligibility.

Courts have carved out broad, judge-made exceptions to patentability, excluding laws of nature,…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Treatments to help utilities prepare for PFAS water regulations 

Environmental Science
June 20, 2025

Powering Drug Development with Advanced Retrosynthetic…

As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges for process…

April 15, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

A Looming En Banc Decision with Potentially Damaging Consequences – EcoFactor v. Google

Proskauer and our platform provider LexBlog each use cookies to personalize content and ads, to provide social media features and…

Biotechnology
April 5, 2025

Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 |

This post could have been “The Revival of the March-In Rights of the Bayh-Dole Act.” The passage of the Bayh-Dole…

Biotechnology
April 26, 2025

Back to District Court? PTAB Strategic Recalibration in Patent Litigation

For years, parallel proceedings at the Patent Trial and Appeal Board (PTAB) were the near-automatic response of a defendant in…

Biotechnology
February 22, 2026

Impact of the Leadership in Critical Technologies Act on U.S. Artificial Intelligence, Semiconductors and Quantum Computing

On the heels of the recent reintroduction of the PERA and PREVAIL Acts of 2025, a bipartisan group of lawmakers…

Biotechnology
June 13, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Powering Drug Development with Advanced Retrosynthetic…
April 15, 2026
AI and Model-Based Tools to Streamline Drug Development
April 15, 2026
Q&A on large-scale commercial expansion at Lonza's Stein…
April 15, 2026
Distribute Your Drug-Manufacturing Risk and Increase Supply…
April 14, 2026

Life Science Magazines

Powering Drug Development with Advanced Retrosynthetic…
April 15, 2026
AI and Model-Based Tools to Streamline Drug Development
April 15, 2026
Q&A on large-scale commercial expansion at Lonza's Stein…
April 15, 2026
Distribute Your Drug-Manufacturing Risk and Increase Supply…
April 14, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?